You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 66 No. 6, June 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Images in Neurology
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Cerebrovascular Disease
 •Cardiovascular System
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Scattered Cerebral Microbleeds Due to Cardiac Myxoma

Peter Vanacker, MD; Natalie Nelissen, MD; Koen Van Laere, MD, PhD; Vincent N. Thijs, MD

Arch Neurol. 2009;66(6):796-797.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Multiple scattered microbleeds on gradient-echo magnetic resonance imaging may be found as a consequence of cerebral microangiopathy due to hypertension, amyloid angiopathy, or hemorrhagic conversion of cardiac emboli or artery to artery embolization.1 Amyloid deposition in the setting of Alzheimer disease or intracerebral hemorrhage can be studied in humans by performing carbon 11 ([11C])–labeled Pittsburgh Compound B positron emission tomography. This positron emission tomography tracer has a high affinity for vascular as well as plaque β-amyloid and is increasingly being used in the evaluation of cognitive disturbance and stroke.2

A 60-year-old woman was admitted with acute onset of left-sided weakness and a National Institutes of Health Stroke Scale score of 4. She was treated with intravenous tissue plasminogen activator after intracerebral hemorrhage was ruled out on computed tomography. Her medical history was unremarkable. Diffusion-weighted . . . [Full Text of this Article]

COMMENT


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.